ConductScience.org, home

Paper8097634

Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications.

Goasguen JE and 8 others. Blood, 1993. Cited by 246 papers, by iCite.

Cite this record

ConductScience Library. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Papers, record 8097634. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8097634

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications.
PubMed
Journal
Blood
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
246
iCite
Relative citation ratio, by iCite
7.71
iCite
Revised in PubMed
2021-02-16
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Goasguen JEJ E
2Dossot JMJ M
3Fardel OO
4Le Mee FF
5Le Gall EE
6Leblay RR
7LePrise PYP Y
8Chaperon JJ
9Fauchet RR

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug ResistanceMajor topic
Membrane GlycoproteinsMajor topic
Precursor Cell Lymphoblastic Leukemia-LymphomaMajor topic
ATP Binding Cassette Transporter, Subfamily B, Member 1
Adolescent
Adult
Antibodies, Monoclonal
Antigens, CD
Bone Marrow
Burkitt Lymphoma
Child
Child, Preschool
Female
Humans
Immunohistochemistry
Immunophenotyping
Karyotyping
Male
Neoplasm Proteins
Prognosis
Survival Analysis
Time Factors

Source PubMed

Download CSV of topics

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in7902138Low incidence of activity of P-glycoprotein (P-170) in de novo acute lymphoblastic leukemia determined by a flow cytometric assay.https://conductscience.org/library/papers/7902138PubMed
Comment in7903172Expression of the multidrug resistance-associated P-glycoprotein (P-170) in acute lymphoblastic leukemia.https://conductscience.org/library/papers/7903172PubMed

Download CSV of comments and corrections

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 246 citations.

PMIDTitleJournalYearIn PapersSource
42064075TLR2 activation potentiates P-glycoprotein-mediated methotrexate efflux and enhances cytotoxicity of human NK cells against acute lymphoblastic leukemia.Front Immunol2026https://conductscience.org/library/papers/42064075PubMed
34985725A Systematic Review of Population Pharmacokinetic Models of Methotrexate.Eur J Drug Metab Pharmacokinet2022https://conductscience.org/library/papers/34985725PubMed
29236701Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines.PLoS One2017https://conductscience.org/library/papers/29236701PubMed
28271337MicroRNAs as prognostic biomarker and relapse indicator in leukemia.Clin Transl Oncol2017https://conductscience.org/library/papers/28271337PubMed
27449773Profiling gene mutations, translocations, and multidrug resistance in pediatric acute lymphoblastic leukemia: a step forward to personalizing medicine.Med Oncol2016https://conductscience.org/library/papers/27449773PubMed
26354033Cytidine deaminase polymorphisms and worse treatment response in normal karyotype AML.J Hum Genet2015https://conductscience.org/library/papers/26354033PubMed
23292860Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy.J Clin Lab Anal2013https://conductscience.org/library/papers/23292860PubMed
23100919Multidrug resistance 1 gene expression and AgNOR in childhood acute leukemias.Indian J Hematol Blood Transfus2007https://conductscience.org/library/papers/23100919PubMed
22942566Expression of P-glycoprotein, Cyclin D1 and Ki-67 in Acute Lymphoblastic Leukemia: Relation with Induction Chemotherapy and Overall Survival.Indian J Hematol Blood Transfus2011https://conductscience.org/library/papers/22942566PubMed
21070600Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia.J Cell Mol Med2011https://conductscience.org/library/papers/21070600PubMed
20055093Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia.J Biomed Nanotechnol2009https://conductscience.org/library/papers/20055093PubMed
19369960Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells.Leukemia2009https://conductscience.org/library/papers/19369960PubMed
17875533
Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
Int J Hematol2007https://conductscience.org/library/papers/17875533PubMed
17429427ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?Leukemia2007https://conductscience.org/library/papers/17429427PubMed
14574327Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.Leukemia2004https://conductscience.org/library/papers/14574327PubMed
11986955Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia.Leukemia2002https://conductscience.org/library/papers/11986955PubMed
11496948Mdr1 transfection causes enhanced apoptosis by paclitaxel: an effect independent of drug efflux function of P-glycoprotein.Pharm Res2001https://conductscience.org/library/papers/11496948PubMed
10958589Development of multidrug-resistance convertors: sense or nonsense?Invest New Drugs2000https://conductscience.org/library/papers/10958589PubMed
10455428A role for intracellular immunization in chemosensitization of tumor cells?Gene Ther1999https://conductscience.org/library/papers/10455428PubMed
9062400Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.Br J Cancer1997https://conductscience.org/library/papers/9062400PubMed

See all 31 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8097634

GET https://conductscience.org/api/papers/v1/8097634/cited_by?page=2